Summary
Latest filing:
Lindsay A. Md Rosenwald is Director of Journey Medical Corp (DERM). 5 SEC Form 4 filings on record going back to 2024, most recently on 26 June 2026.
Recent Transactions
5Every recent SEC Form 4 transaction Lindsay A. Md Rosenwald has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Lindsay A. Md Rosenwald's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Daniel Allen Gold - $147.38M of ROIV open-market activity in the last 12 months
- QVT Financial LP - $147.38M of ROIV open-market activity in the last 12 months
- ULSE Inc. - $146.25M of ULS open-market activity in the last 12 months
- BAIN CAPITAL INVESTORS LLC - $134.38M of KLRA open-market activity in the last 12 months
- Andrew T. Kaplan - $134.38M of KLRA open-market activity in the last 12 months
- Fairmount Funds Management LLC - $133.53M of APGE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Lindsay A. Md Rosenwald?
Lindsay A. Md Rosenwald is a corporate insider, tracked as Director of Journey Medical Corp (DERM). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Lindsay A. Md Rosenwald submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Lindsay A. Md Rosenwald's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Lindsay A. Md Rosenwald and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
